加拿大老龄化纵向研究中绝经年龄、血管风险与3年认知变化的关联
研究基于加拿大老龄化纵向研究,纳入8360名绝经后女性和8360名年龄匹配男性,分析绝经年龄、血管风险与含雌激素激素治疗史对3年认知变化的共同影响。结果显示较早绝经与较高血管风险协同关联随访时较低认知评分,激素治疗史未进一步修饰该关联。
要点
- 绝经年龄与血管风险存在交互作用,协同关联随访认知评分(β=0.013,95%CI 0.001-0.025,p=0.03)。
- 较早绝经(35-48岁)女性中血管风险与较低认知评分相关(β=-0.044,95%CI -0.066至-0.022,p<0.001)。
- 平均(49-52岁)或较晚(53-65岁)绝经女性中血管风险与认知评分无显著关联。
核心结论
- 内分泌与血管过程可能协同导致女性成人认知下降风险增加。
- 这些发现对制定性别特异性痴呆预防策略有启示。
研究设计与样本
- 使用加拿大老龄化纵向研究中绝经后女性参与者及年龄匹配男性参与者的数据。
- 血管风险采用包含血压升高、降压药物、低密度脂蛋白胆固醇升高、糖尿病、吸烟和肥胖的汇总评分计算。
- 认知在基线和3年随访时采用全局认知复合评分测量。
- 线性模型检验绝经年龄、血管风险与激素治疗史对3年随访认知的独立和交互关联,并调整基线认知、基线年龄、受教育年限和测试语言(英语/法语)。
- 纳入8360名绝经后女性参与者(基线平均年龄65.0±8.53岁,平均绝经年龄50.1±4.62岁)和8360名年龄匹配男性参与者进行比较。
主要发现
- 绝经年龄与血管风险存在交互作用,较早绝经与较高血管风险协同关联随访时较低认知评分(β=0.013,95%CI 0.001-0.025,p=0.03)。
- 分层分析中,较早绝经(绝经年龄35-48岁)女性血管风险与较低认知评分相关(β=-0.044,95%CI -0.066至-0.022,p<0.001)。
- 平均绝经年龄(49-52岁)女性中血管风险与认知评分无显著关联(β=-0.007,95%CI -0.027至0.012,p=0.46)。
- 较晚绝经年龄(53-65岁)女性中血管风险与认知评分无显著关联(β=0.003,95%CI -0.020至0.025,p=0.82)。
- 较早绝经女性中血管风险与认知的负向关联强于年龄匹配男性中的相应关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Mounting evidence supports sex differences in Alzheimer disease (AD) risk. Vascular and hormonal factors may together contribute to AD risk in female adults. We investigated whether age at menopause, vascular risk, and history of hormone therapy (HT) containing estrogens together influence cognition over a 3-year follow-up period. We hypothesized that earlier menopause and elevated vascular risk would have a synergistic association with lower cognitive scores at follow-up and that HT containing estrogens would attenuate this synergistic association to preserve cognition. METHODS: We used data from postmenopausal female participants and age-matched male participants in the Canadian Longitudinal Study on Aging. Vascular risk was calculated using a summary score of elevated blood pressure, antihypertensive medications, elevated low-density lipoprotein cholesterol, diabetes, smoking, and obesity. Cognition was measured with a global cognitive composite at baseline and 3-year follow-up. Linear models tested independent and interactive associations of age at menopause, vascular risk, and HT history with cognition at 3-year follow-up, adjusting for baseline cognition, baseline age, years of education, and test language (English/French). RESULTS: We included 8,360 postmenopausal female participants (mean age at baseline = 65.0 ± 8.53 years, mean age at menopause = 50.1 ± 4.62 years) and 8,360 age-matched male participants for comparison. There was an interaction between age at menopause and vascular risk, such that earlier menopause and higher vascular risk were synergistically associated with lower cognitive scores at follow-up (β = 0.013, 95% CI 0.001-0.025, p = 0.03). In stratified analyses, vascular risk was associated with lower cognitive scores in female participants with earlier menopause (menopausal ages 35-48 years; β = -0.044, 95% CI -0.066 to -0.022, p < 0.001), but not average (ages 49-52 years; β = -0.007, 95% CI -0.027 to 0.012, p = 0.46) or later menopause (ages 53-65 years; β = 0.003, 95% CI -0.020 to 0.025, p = 0.82). The negative association of vascular risk with cognition in female participants with earlier menopause was stronger than the equivalent association in age-matched male participants. HT history did not further modify the synergistic association of age at menopause and vascular risk with follow-up cognition (β = -0.005, 95% CI -0.032 to 0.021, p = 0.69). DISCUSSION: Endocrine and vascular processes may synergistically contribute to increased risk of cognitive decline in female adults. These findings have implications for the development of sex-specific dementia prevention strategies.
引用
- Wood Alexander M, Wu CY, Coughlan GT, et al. Associations Between Age at Menopause, Vascular Risk, and 3-Year Cognitive Change in the Canadian Longitudinal Study on Aging. Neurology. 2024. PMID: 38569140. doi:10.1212/WNL.0000000000209298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。